{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:04:30Z","timestamp":1782237870392,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["D2018011"],"award-info":[{"award-number":["D2018011"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["Xld202208"],"award-info":[{"award-number":["Xld202208"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jpba.2024.116387","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T10:00:52Z","timestamp":1722160852000},"page":"116387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Simultaneous quantification of baloxavir marboxil and its active metabolite in human plasma using UHPLC-MS\/MS: Application to a human pharmacokinetic study with different anticoagulants"],"prefix":"10.1016","volume":"249","author":[{"given":"Haiyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.jpba.2024.116387_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jpba.2024.116387_bib2","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1093\/cid\/ciac734","article-title":"The spectrum of influenza in children","volume":"76","author":"Hoy","year":"2023","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.jpba.2024.116387_bib3","unstructured":"Recommendations for Prevention and Control of Influenza in Children, 2023\u20132024, Pediatrics 152(4) (2023)."},{"key":"10.1016\/j.jpba.2024.116387_bib4","unstructured":"Xofluza(baloxavir marboxil) tablets,for oral use Initial U.S. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210854Orig1s000ClinPharmR.pdf, (accessed 5 December 2022.)."},{"key":"10.1016\/j.jpba.2024.116387_bib5","unstructured":"Roche: European Commission Approves Xofluza For Children Aged One Year And Above. https:\/\/www.nasdaq.com\/articles\/roche:-european-commission-approves-xofluza-for-children-aged-one-year-and-above)."},{"key":"10.1016\/j.jpba.2024.116387_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","article-title":"In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit","volume":"160","author":"Noshi","year":"2018","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.jpba.2024.116387_bib7","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.xphs.2018.12.005","article-title":"Population Pharmacokinetic and Exposure-Response Analyses of Baloxavir Marboxil in Adults and Adolescents Including Patients With Influenza","volume":"108","author":"Koshimichi","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2024.116387_bib8","unstructured":"Xofluza, Xofluza prescribing information. https:\/\/www.accessdata.fda.gov\/drugs atfda_docs\/label\/ 2019\/21085 4s001 lbl.pdf, (accessed January 7,.2022)."},{"issue":"8","key":"10.1016\/j.jpba.2024.116387_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5644","article-title":"Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods","volume":"37","author":"Nagulancha","year":"2023","journal-title":"Biomed. Chromatogr.: BMC"},{"issue":"14","key":"10.1016\/j.jpba.2024.116387_bib10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/jssc.202200020","article-title":"Kinetic degradation study for the first licensed anti-influenza polymerase inhibitor, baloxavir marboxil, using high-performance liquid chromatography-mass spectrometry","volume":"45","author":"Hafez","year":"2022","journal-title":"J. Sep. Sci."},{"issue":"11","key":"10.1016\/j.jpba.2024.116387_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5729","article-title":"Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies","volume":"37","author":"Mu","year":"2023","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.jpba.2024.116387_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115165","article-title":"LC-MS\/MS-based metabolite quantitation of the antiviral prodrug baloxavir marboxil, a new therapy for acute uncomplicated influenza, in human plasma: application to a human pharmacokinetic study","volume":"223","author":"Gouda","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpba.2024.116387_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cts.13160","article-title":"Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects","volume":"15","author":"Kim","year":"2022","journal-title":"Clin. Transl. Sci."},{"issue":"5","key":"10.1016\/j.jpba.2024.116387_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/cts.13237","article-title":"Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals","volume":"15","author":"Liu","year":"2022","journal-title":"Clin. Transl. Sci."},{"issue":"12","key":"10.1016\/j.jpba.2024.116387_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40261-018-0710-9","article-title":"Safety, tolerability, and pharmacokinetics of the novel anti-influenza agent baloxavir marboxil in healthy adults: phase I study findings","volume":"38","author":"Koshimichi","year":"2018","journal-title":"Clin. Drug Investig."},{"issue":"1","key":"10.1016\/j.jpba.2024.116387_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/00498250701678955","article-title":"Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin","volume":"38","author":"Chen","year":"2008","journal-title":"Xenobiotica\u00a0Fate Foreign Compd. Biol. Syst."},{"issue":"1","key":"10.1016\/j.jpba.2024.116387_bib17","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1186\/s40064-016-3770-4","article-title":"Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs","volume":"5","author":"Kulkarni","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.jpba.2024.116387_bib18","unstructured":"FDA, Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Center for Drug Evaluation and Research and Center for Veterinary Medicine, US Food and Drug Administration (2018).."},{"key":"10.1016\/j.jpba.2024.116387_bib19","unstructured":"ICH harmonized Guideline\uff0cBioanalytical Method Validation and Study Sample Analysis (M10). https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf, 2022).."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:01:11Z","timestamp":1778752871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524004278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":19,"alternative-id":["S0731708524004278"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116387","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of baloxavir marboxil and its active metabolite in human plasma using UHPLC-MS\/MS: Application to a human pharmacokinetic study with different anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116387"}}